Genomictree Inc Stocks - 228760.KS rate on the chart online today: price forecast, profitability, dividends – Oninvest

Review

Evaluation

Target price

Dynamics

Performance

Growth

Dividends

Risks

₩ 0

Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only

Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only

Data is available to registered users only

Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts

Sign up to access all the key risk and return factors

Risks

Default risk
Data is available to registered users only
Volatility
Data is available to registered users only
Selling difficulty
Data is available to registered users only
Stress test
Data is available to registered users only
Country risks
Data is available to registered users only
Other risks
Data is available to registered users only

Sign up to access detailed risk analysis

About

Genomictree Inc is a molecular diagnostic company. It is engaged in developing technologies that satisfies the unmet needs of the healthcare market.

Greatly overvalued

1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks.

Data is available to registered users only

Sign up to access detailed valuation

Risks

Default risk
Data is available to registered users only
Volatility
Data is available to registered users only
Selling difficulty
Data is available to registered users only
Stress test
Data is available to registered users only
Country risks
Data is available to registered users only
Other risks
Data is available to registered users only

Sign up to access detailed risk analysis